DE3364234D1 - Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient - Google Patents

Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient

Info

Publication number
DE3364234D1
DE3364234D1 DE8383102019T DE3364234T DE3364234D1 DE 3364234 D1 DE3364234 D1 DE 3364234D1 DE 8383102019 T DE8383102019 T DE 8383102019T DE 3364234 T DE3364234 T DE 3364234T DE 3364234 D1 DE3364234 D1 DE 3364234D1
Authority
DE
Germany
Prior art keywords
antiphlogistic
antipyretic
active ingredient
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383102019T
Other languages
English (en)
Inventor
Takeru Kaneko
Satoru Ozaki
Kimie Takizawa
Hachiro Sugimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3168582A external-priority patent/JPS58148819A/ja
Priority claimed from JP3168482A external-priority patent/JPS58148818A/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3364234D1 publication Critical patent/DE3364234D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8383102019T 1982-03-02 1983-03-02 Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient Expired DE3364234D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3168582A JPS58148819A (ja) 1982-03-02 1982-03-02 テオブロミン誘導体を有効成分とする消炎・解熱・鎮痛剤
JP3168482A JPS58148818A (ja) 1982-03-02 1982-03-02 テオフイリン誘導体を有効成分とする消炎・解熱・鎮痛剤

Publications (1)

Publication Number Publication Date
DE3364234D1 true DE3364234D1 (en) 1986-07-31

Family

ID=26370191

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8383102019T Expired DE3364234D1 (en) 1982-03-02 1983-03-02 Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient
DE19833307395 Withdrawn DE3307395A1 (de) 1982-03-02 1983-03-02 Arzneimittel zur behandlung von schmerzen, fieber, gewebe- und/oder knochen- und gelenkentzuendungen mit einem gehalt an theobromin- oder theophyllinderivaten als aktivem bestandteil

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19833307395 Withdrawn DE3307395A1 (de) 1982-03-02 1983-03-02 Arzneimittel zur behandlung von schmerzen, fieber, gewebe- und/oder knochen- und gelenkentzuendungen mit einem gehalt an theobromin- oder theophyllinderivaten als aktivem bestandteil

Country Status (4)

Country Link
US (1) US4543254A (de)
EP (1) EP0087810B1 (de)
DE (2) DE3364234D1 (de)
IT (1) IT1161591B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES506046A0 (es) * 1981-10-06 1983-02-01 Invest Tecnica Aplicada Procedimiento de obtencion de nuevas xantinas con actividad farmacologica
NL8700245A (nl) * 1986-02-14 1987-09-01 Sandoz Ag Purinederivaten, werkwijzen voor hun bereiding en geneesmiddelen die deze derivaten bevatten.
CA1297035C (en) * 1987-12-29 1992-03-10 Warner-Lambert Canada Inc. Chewable, non-gritty calcium citrate tablet
US4876257A (en) * 1988-03-03 1989-10-24 Ortho Pharmaceutical Corporation 6-Substituted purinyl piperazine derivatives useful as cardiotonic and antiarrhythmic agents
US5021574A (en) * 1988-03-03 1991-06-04 Ortho Pharmaceutical Corporation 6-substituted purinyl piperazine derivatives
US5164390A (en) * 1988-03-03 1992-11-17 Ortho Pharmaceutical Corporation 6-substituted purinyl piperazine derivatives
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles
WO1999014203A1 (fr) 1997-09-16 1999-03-25 Takeda Chemical Industries, Ltd. Composes azotes a cycles condenses, procede de preparation de ces composes et medicaments
US20050209243A1 (en) * 2002-09-27 2005-09-22 Ing-Jun Chen Theophylline-based soluble guanylyl cyclase activators KMUP-1 analogues enhanced cyclic GMP and K+ channel activities on rabbit corpus cavernosum smooth muscle and intercavernous pressure activities
US6979687B1 (en) * 2002-09-27 2005-12-27 Ing-Jun Chen Theophylline-based soluble guanylyl cyclase activators KMUP-1 analogues enhanced cyclic GMP and K+ channel activities on rabbit corpus cavernosum smooth muscle and intercavernous pressure activities
CN1809545A (zh) * 2003-06-20 2006-07-26 艾尼纳制药公司 N－苯基－哌嗪衍生物和预防或者治疗5HT2c受体相关疾病的方法
EP1844792A4 (de) * 2004-12-14 2008-05-21 Shionogi & Co Therapeutisches mittel gegen obstipation
HUE031039T2 (en) * 2007-03-29 2017-06-28 Joint-Stock Company Obninsk Chemical Pharmaceutical Company An antihistamine and an anti-allergenic agent and a method for its preparation
RU2333212C3 (ru) * 2007-03-29 2019-08-26 Общество С Ограниченной Ответственностью "Фармвинг" ПРОИЗВОДНЫЕ 1-И 7-[ω-(БЕНЗГИДРИЛ-4-ПИПЕРАЗИНИЛ-1)АЛКИЛ]-3-АЛКИЛКСАНТИНОВ, ОБЛАДАЮЩИЕ ПРОТИВОГИСТАМИННОЙ И АНТИАЛЛЕРГИЧЕСКОЙ АКТИВНОСТЬЮ
EP3663295A1 (de) 2007-06-22 2020-06-10 Eli Lilly And Co. 2,6-dioxo,-2,3-dihydro-1h-purin-verbindungen zur behandlung von erkrankungen im zusammenhang mit der aktivierung des trpa1 kanals
AU2015202546B8 (en) * 2007-06-22 2017-03-09 Eli Lilly And Company Methods and Compositions for Treating Disorders
WO2009140517A1 (en) 2008-05-14 2009-11-19 Hydra Biosciences, Inc. Compounds and compositions for treating chemical warfare agent-induced injuries
TWI368511B (en) * 2009-04-30 2012-07-21 Univ Kaohsiung Medical Synthesis and pharmacokinetic activities of pulmodil and pulmodil-1, two chlorophenylpiperazine salt derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545717A1 (de) * 1965-12-06 1969-07-24 Chugai Pharmaceutical Co Ltd Verfahren zur Herstellung von Theophyllinderivaten
DD143179B1 (de) * 1979-05-16 1983-03-30 Georg Diederich Verfahren zur elektronischen thrombozytenzaehlung
JPS5618983A (en) * 1979-07-25 1981-02-23 Eisai Co Ltd Theophylline derivative and its preapration
CH648559A5 (de) * 1981-07-20 1985-03-29 Siegfried Ag Theophyllinderivate und verfahren zu deren herstellung.
US4374837A (en) * 1981-07-31 1983-02-22 Laroche Navarron, S.A. Piperazine derivatives of theobromine

Also Published As

Publication number Publication date
EP0087810B1 (de) 1986-06-25
IT1161591B (it) 1987-03-18
IT8319857A0 (it) 1983-03-02
DE3307395A1 (de) 1983-09-08
EP0087810A1 (de) 1983-09-07
US4543254A (en) 1985-09-24

Similar Documents

Publication Publication Date Title
DE3364234D1 (en) Antiphlogistic/antipyretic/analgesic pharmaceutical compositions containing theophylline derivatives as active ingredient
GB2098064B (en) Pharmaceutical formulations comprising imidazole derivatives and salts thereof
DE2965284D1 (en) Pharmaceutical compositions for topical administration containing prostaglandins
GB2143734B (en) Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
IL60326A0 (en) Pharmaceutical compositions for parenteral administration of fatsolbule active substances
DE3172028D1 (en) Pharmaceutical formulation
ZA828797B (en) Pharmaceutical formulation
GB2105193B (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory agents
PT77016B (en) Process for the preparation of topical anti-inflammatory compositions containing pyroxycame as active ingredient
DE3367849D1 (en) Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives
DE2963061D1 (en) Hydantoin compounds, their preparation and pharmaceutical formulations containing them
NZ190966A (en) Prostanoid compounds and pharmaceutical compositions
IL74049A0 (en) Controlled release liquid dosage pharmaceutical formulations
ZA787000B (en) Pharmaceutical formulation
AU525125B2 (en) Controlled-release pharmaceutical dosage component
JPS55111494A (en) Monophosphonate compound* its manufacture and therapeutic composition containing same as active ingredient
ZA79395B (en) Pharmaceutical formulations
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
GB2070591B (en) Prostanoid compounds and their preparation and pharmaceutical formulation
IL58621A0 (en) Pharmaceutical compositions comprising aryltrifluoroethanol derivatives
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
DE2860796D1 (en) Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them
IL57436A0 (en) Hydantoin derivatives and pharmaceutical compositions containing them
DE3163391D1 (en) A pharmaceutical composition containing a benzofuran-carboxamide derivative as the active ingredient
GB2105588B (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory agents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee